Evaluation of Biomarker Levels in Blood, Saliva and Gingival Fluid in Periodontitis
Evaluation of Ischemic Modified Albumin, Catalase, Reduced Glutathione, Malondialdehyde, Adenosine Deaminase Levels in Blood, Saliva and Gingival Fluid in Periodontitis
1 other identifier
observational
40
1 country
1
Brief Summary
The aim of this study was to compare IMA, MDA, CAT, GSH and ADA levels in gingival crevicular fluid, serum and saliva of periodontally hopeless, periodontitis and gingivitis teeth with healthy control groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
November 17, 2020
CompletedFirst Posted
Study publicly available on registry
November 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedNovember 30, 2020
November 1, 2020
1.1 years
November 17, 2020
November 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
adenosine deaminase
Adenosine deaminase (ADA) is an enzyme involved in proliferation and differentiation. Although ADA has been investigated in different inflammatory and infectious diseases and has been defined as an immunoenzyme biomarker, its role in periodontitis has not been fully elucidated yet.
1 year
catalase
Catalase (CAT) decomposes H2O2 catalyzed by superoxide dismutase (SOD) into H2O and O2. (13) It is stated in the literature that CAT, SOD and total oxidant state are important biomarkers that can be used in the diagnosis of periodontal disease and evaluation of treatment results. (14)
1 year
Ischemia-modified albumin
Ischemia-modified albumin (IMA) is suggested as an oxidative stress marker and an indicator of inflammatory diseases. It has been reported in the literature that the serum IMA level increases significantly in the case of periodontal disease and decreases after treatment. In this respect, it has been stated that IMA can be an indicator of systemic inflammation caused by periodontal disease.
1 year
malondialdehide
In periodontal disease, an increase in reactive oxygen species and a decrease in antioxidant activity are observed because this disease is thought to be associated with an imbalance between antioxidants and oxidants. (8) Lipid peroxidation is a result of periodontitis. Free radicals that lead to the production of toxic and reactive aldehyde metabolites such as malondialdehyde (MDA) cause lipid peroxidation. (9) It is among the information in the literature that MDA levels increase in the case of periodontal inflammation and that MDA can be considered as an oxidative stress marker for periodontitis. (10-12)
1 year
glutathione
Glutathione (GSH) acts as a coenzyme in the oxidation-reduction process. (15) GSH is a critical redox regulator and important for the health of peridontium
1 year
Study Arms (4)
Hopeless teeth
The teeth that can not be treated periodontally and who are desperate for extraction will be included in this group.
Periodontitis
Teeth diagnosed with periodontitis will be included in this group.
Gingivitis
Teeth diagnosed with gingivitis will be included in this group.
Healthy
Teeth diagnosed with helthy will be included in this group.
Interventions
No intervention was applied to the groups the samples will be collected in terms of the diagnosis (hopeless, periodontitis, gingivitis, healthy)
Eligibility Criteria
Systemically healhty ,non-smokers,non-pregnants will be included in the study
You may qualify if:
- Systemically healhty non-smokers non-pregnants -
You may not qualify if:
- \- Patients with systemic disease smokers pregnants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Van yuzuncu yil university
Van, 65080, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
hacer sahin aydınyurtt, assoc. prof
Yuzuncu Yil University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 15 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
November 17, 2020
First Posted
November 30, 2020
Study Start
January 1, 2020
Primary Completion
February 1, 2021
Study Completion
March 1, 2021
Last Updated
November 30, 2020
Record last verified: 2020-11